Home LiteratureArticle Details
PMID: 15220440 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Replication of herpes simplex virus 1 depends on the gamma 134.5 functions that facilitate virus response to interferon and egress in the different stages of productive infection.

Journal of virology ·Vol. 78 ·No. 14 ·2004-07-00 ·Pages 7653-66

Jing X, Cerveny M, Yang K, He B

Abstract

The ability of the gamma(1)34.5 protein to suppress the PKR response plays a crucial role in herpes simplex virus pathogenesis. In this process, the gamma(1)34.5 protein associates with protein phosphatase 1 to form a large complex that dephosphorylates eIF-2alpha and thereby prevents translation shutoff mediated by PKR. Accordingly, gamma(1)34.5 null mutants are virulent in PKR-knockout mice but not in wild-type mice. However, gamma(1)34.5 deletion mutants, with an extragenic compensatory mutation, inhibit PKR activity but remain avirulent, suggesting that the gamma(1)34.5 protein has additional functions. Here, we show that a substitution of the gamma(1)34.5 gene with the NS1 gene from influenza A virus renders viral resistance to interferon involving PKR. The virus replicates as efficiently as wild-type virus in SK-N-SH and CV-1 cells. However, in mouse 3T6 cells, the virus expressing the NS1 protein grows at an intermediate level between the wild-type virus and the gamma(1)34.5 deletion mutant. This decrease in growth, compared to that of the wild-type virus, is due not to an inhibition of viral protein synthesis but rather to a block in virus release or egress. Virus particles are predominantly present in the nucleus and cytoplasm. Notably, deletions in the amino terminus of the gamma(1)34.5 protein lead to a significant decrease in virus growth in mouse 3T6 cells, which is independent of eIF-2alpha dephosphorylation. In correlation, a series of deletions in the amino-terminal domain impair nuclear as well as cytoplasmic egress. These results indicate that efficient viral replication depends on the gamma(1)34.5 functions required to prevent the PKR response and to facilitate virus egress in the different stages during virus infection.

MeSH Terms
Animals Antiviral Agents/pharmacology Cell Line Chlorocebus aethiops Gene Deletion Herpesvirus 1, Human/drug effects,genetics,pathogenicity,physiology Humans Interferon-alpha/pharmacology Mice Recombination, Genetic/genetics Vero Cells Viral Nonstructural Proteins/genetics Viral Proteins/genetics,metabolism Virus Replication/physiology eIF-2 Kinase/genetics,metabolism
Chemicals
Antiviral Agents INS1 protein, influenza virus Interferon-alpha Viral Nonstructural Proteins Viral Proteins gamma 34.5 protein, Human herpesvirus 1 eIF-2 Kinase
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Jing Xianghong
Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
Cerveny Melissa
Yang Kui
He Bin
References (51)
51 references, click to expand
  1. A herpesvirus genetic element which affects translation in the absence of the viral GADD34 function.
    EMBO J. 1996 Sep 2;15(17):4759-66 PMID: 8887567
  2. Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene.
    Proc Natl Acad Sci U S A. 2000 May 23;97(11):6097-101 PMID: 10801979
  3. The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase.
    Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):843-8 PMID: 9023344
  4. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication.
    J Virol. 2000 Jul;74(13):6203-6 PMID: 10846107
  5. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein.
    J Virol. 2000 Sep;74(17):7989-96 PMID: 10933707
  6. The Ebola virus VP35 protein functions as a type I IFN antagonist.
    Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12289-94 PMID: 11027311
  7. AlaArg motif in the carboxyl terminus of the gamma(1)34.5 protein of herpes simplex virus type 1 is required for the formation of a high-molecular-weight complex that dephosphorylates eIF-2alpha.
    J Virol. 2001 Apr;75(8):3666-74 PMID: 11264356
  8. A herpes simplex virus type 1 gamma34.5 second-site suppressor mutant that exhibits enhanced growth in cultured glioblastoma cells is severely attenuated in animals.
    J Virol. 2001 Jun;75(11):5189-96 PMID: 11333900
  9. Herpes simplex virus infections.
    Lancet. 2001 May 12;357(9267):1513-8 PMID: 11377626
  10. Second-site mutation outside of the U(S)10-12 domain of Deltagamma(1)34.5 herpes simplex virus 1 recombinant blocks the shutoff of protein synthesis induced by activated protein kinase R and partially restores neurovirulence.
    J Virol. 2002 Feb;76(3):942-9 PMID: 11773369
  11. Regulation of starvation- and virus-induced autophagy by the eIF2alpha kinase signaling pathway.
    Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):190-5 PMID: 11756670
  12. Val193 and Phe195 of the gamma 1 34.5 protein of herpes simplex virus 1 are required for viral resistance to interferon-alpha/beta.
    Virology. 2001 Nov 10;290(1):115-20 PMID: 11882996
  13. An N-terminal arginine-rich cluster and a proline-alanine-threonine repeat region determine the cellular localization of the herpes simplex virus type 1 ICP34.5 protein and its ligand, protein phosphatase 1.
    J Biol Chem. 2002 Mar 29;277(13):11423-31 PMID: 11788604
  14. Cell surface major histocompatibility complex class II proteins are regulated by the products of the gamma(1)34.5 and U(L)41 genes of herpes simplex virus 1.
    J Virol. 2002 Jul;76(14):6974-86 PMID: 12072498
  15. Signals that dictate nuclear, nucleolar, and cytoplasmic shuttling of the gamma(1)34.5 protein of herpes simplex virus type 1.
    J Virol. 2002 Sep;76(18):9434-45 PMID: 12186925
  16. Strain-dependent structural variants of herpes simplex virus type 1 ICP34.5 determine viral plaque size, efficiency of glycoprotein processing, and viral release and neuroinvasive disease potential.
    J Virol. 2003 Mar;77(6):3409-17 PMID: 12610116
  17. In vivo replication of an ICP34.5 second-site suppressor mutant following corneal infection correlates with in vitro regulation of eIF2 alpha phosphorylation.
    J Virol. 2003 Apr;77(8):4626-34 PMID: 12663769
  18. Amino acid substitutions in the effector domain of the gamma(1)34.5 protein of herpes simplex virus 1 have differential effects on viral response to interferon-alpha.
    Virology. 2003 Mar 15;307(2):290-300 PMID: 12667799
  19. The herpes simplex virus (HSV) protein ICP34.5 is a virion component that forms a DNA-binding complex with proliferating cell nuclear antigen and HSV replication proteins.
    J Neurovirol. 2003 Aug;9(4):477-88 PMID: 12907392
  20. Dephosphorylation of eIF-2alpha mediated by the gamma(1)34.5 protein of herpes simplex virus type 1 is required for viral response to interferon but is not sufficient for efficient viral replication.
    J Virol. 2003 Sep;77(18):10154-61 PMID: 12941928
  21. Inverted repetitions in the chromosome of herpes simplex virus.
    Cold Spring Harb Symp Quant Biol. 1975;39 Pt 2:667-78 PMID: 169022
  22. The terminal a sequence of the herpes simplex virus genome contains the promoter of a gene located in the repeat sequences of the L component.
    J Virol. 1986 Feb;57(2):629-37 PMID: 3003394
  23. Identification by antibody to a synthetic peptide of a protein specified by a diploid gene located in the terminal repeats of the L component of herpes simplex virus genome.
    J Virol. 1986 Jun;58(3):843-50 PMID: 3009891
  24. The herpes simplex virus 1 gene for ICP34.5, which maps in inverted repeats, is conserved in several limited-passage isolates but not in strain 17syn+.
    J Virol. 1990 Mar;64(3):1014-20 PMID: 2154589
  25. Sequence of MyD116 cDNA: a novel myeloid differentiation primary response gene induced by IL6.
    Nucleic Acids Res. 1990 May 11;18(9):2823 PMID: 2339071
  26. Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture.
    Science. 1990 Nov 30;250(4985):1262-6 PMID: 2173860
  27. Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the 'a' sequence.
    J Gen Virol. 1991 Mar;72 ( Pt 3):631-9 PMID: 1848598
  28. The RL neurovirulence locus in herpes simplex virus type 2 strain HG52 plays no role in latency.
    J Gen Virol. 1991 Sep;72 ( Pt 9):2305-10 PMID: 1654382
  29. Comparative sequence analysis of the long repeat regions and adjoining parts of the long unique regions in the genomes of herpes simplex viruses types 1 and 2.
    J Gen Virol. 1991 Dec;72 ( Pt 12):3057-75 PMID: 1662697
  30. The gamma 1(34.5) gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programed cell death in neuronal cells.
    Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3266-70 PMID: 1314384
  31. Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models.
    J Clin Invest. 1993 Jun;91(6):2837-43 PMID: 8390490
  32. The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth.
    Mol Cell Biol. 1994 Apr;14(4):2361-71 PMID: 8139541
  33. Herpes simplex virus 1 gamma(1)34.5 gene function, which blocks the host response to infection, maps in the homologous domain of the genes expressed during growth arrest and DNA damage.
    Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5247-51 PMID: 8202476
  34. The herpes simplex virus type 1 strain 17+ gamma 34.5 deletion mutant 1716 is avirulent in SCID mice.
    J Gen Virol. 1994 Aug;75 ( Pt 8):2059-63 PMID: 8046409
  35. Cell type and cell state determine differential in vitro growth of non-neurovirulent ICP34.5-negative herpes simplex virus types 1 and 2.
    J Gen Virol. 1994 Sep;75 ( Pt 9):2367-77 PMID: 8077935
  36. ICP34.5 influences herpes simplex virus type 1 maturation and egress from infected cells in vitro.
    J Gen Virol. 1994 Dec;75 ( Pt 12):3679-86 PMID: 7996163
  37. Association of a M(r) 90,000 phosphoprotein with protein kinase PKR in cells exhibiting enhanced phosphorylation of translation initiation factor eIF-2 alpha and premature shutoff of protein synthesis after infection with gamma 134.5- mutants of herpes simplex virus 1.
    Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10516-20 PMID: 7479831
  38. A block in glycoprotein processing correlates with small plaque morphology and virion targetting to cell-cell junctions for an oral and an anal strain of herpes simplex virus type-1.
    Arch Virol. 1995;140(12):2163-81 PMID: 8572939
  39. The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors.
    Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11313-8 PMID: 8876132
  40. Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors.
    Cancer Res. 1997 Apr 15;57(8):1502-9 PMID: 9108452
  41. The herpes simplex virus virulence factor ICP34.5 and the cellular protein MyD116 complex with proliferating cell nuclear antigen through the 63-amino-acid domain conserved in ICP34.5, MyD116, and GADD34.
    J Virol. 1997 Dec;71(12):9442-9 PMID: 9371605
  42. The gamma134.5 protein of herpes simplex virus 1 has the structural and functional attributes of a protein phosphatase 1 regulatory subunit and is present in a high molecular weight complex with the enzyme in infected cells.
    J Biol Chem. 1998 Aug 14;273(33):20737-43 PMID: 9694816
  43. The second-site mutation in the herpes simplex virus recombinants lacking the gamma134.5 genes precludes shutoff of protein synthesis by blocking the phosphorylation of eIF-2alpha.
    J Virol. 1998 Sep;72(9):7005-11 PMID: 9696792
  44. Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase.
    J Interferon Cytokine Res. 1998 Sep;18(9):757-66 PMID: 9781815
  45. Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells.
    J Virol. 1999 Mar;73(3):2425-33 PMID: 9971827
  46. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo.
    J Exp Med. 1999 Feb 15;189(4):663-72 PMID: 9989981
  47. Nuclear and nucleolar localization of an African swine fever virus protein, I14L, that is similar to the herpes simplex virus-encoded virulence factor ICP34.5.
    J Gen Virol. 1999 Mar;80 ( Pt 3):525-35 PMID: 10091989
  48. Intrastrain variants of herpes simplex virus type 1 isolated from a neonate with fatal disseminated infection differ in the ICP34.5 gene, glycoprotein processing, and neuroinvasiveness.
    J Virol. 1999 May;73(5):3843-53 PMID: 10196279
  49. Allele replacement: an application that permits rapid manipulation of herpes simplex virus type 1 genomes.
    Gene Ther. 1999 May;6(5):922-30 PMID: 10505118
  50. Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells.
    J Gen Virol. 1968 May;2(3):357-64 PMID: 4300104
  51. An African swine fever virus virulence-associated gene NL-S with similarity to the herpes simplex virus ICP34.5 gene.
    J Virol. 1996 Dec;70(12):8865-71 PMID: 8971015
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2004-07-00
Pages
7653-66
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC434106
Subset
IM
Grants
NIAID NIH HHS · R01 AI046665 · United States
NIAID NIH HHS · R56 AI046665 · United States
NIAID NIH HHS · AI 46665 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com